A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

Development of resistance to gemcitabine is a major concern in bladder cancer therapy, and the mechanism remains unclear. Eg5 has been recently identified as an attractive target in cancer chemotherapy, so novel targeted chemotherapy with Eg5 inhibitor is expected to improve the anticancer effect in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Liang, Lu, Jiaju, Niu, Zhihong, Ding, Kejia, Bi, Dongbin, Liu, Shuai, Li, Jiamei, Wu, Fei, Zhang, Hui, Zhao, Zuohui, Ding, Sentai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675549/
https://www.ncbi.nlm.nih.gov/pubmed/26658059
http://dx.doi.org/10.1371/journal.pone.0144484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675549/
https://www.ncbi.nlm.nih.gov/pubmed/26658059
http://dx.doi.org/10.1371/journal.pone.0144484

Ejemplares similares